By Jessica Kenley, Monarch Media

POTTER COUNTY, Pa. — In a rural county where resources are already scarce, access to a key medication used to treat opioid addiction remains out of reach for many residents—raising concerns among advocates who say the system is failing those most in need of help.

Suboxone, a medication widely used in medication-assisted treatment (MAT) for opioid use disorder, is largely unavailable at local pharmacies in Potter County. For individuals seeking recovery, that absence can mean the difference between stability and relapse.

At the center of the issue is a policy at Coudersport Pharmacy, part of Darling’s Family of Services, owned by Chris Darling. According to a pharmacist at the location, the pharmacy does not carry Suboxone due to “store policy.” Attempts by Monarch Media to reach Darling for further clarification were unsuccessful.

The pharmacist cited two primary reasons for the policy: low reimbursement rates from Medicaid and federal limits on the amount of controlled substances pharmacies are permitted to stock each month under regulations from the U.S. Drug Enforcement Administration. However, it remains unclear to what extent these factors directly impact the ability—or decision—not to carry Suboxone.

Despite not stocking the medication for the general public, Coudersport Pharmacy does provide Suboxone to inmates at the Potter County Jail through a contractual agreement. The pharmacy also dispenses Narcan, a life-saving opioid overdose reversal drug, and provides syringes over the counter—both recognized harm reduction tools.

For residents outside the jail system, the nearest pharmacy known to fill Suboxone prescriptions is located in Bradford, Pennsylvania—approximately an hour’s drive from much of Potter County. For individuals without reliable transportation, that distance can be an insurmountable barrier.

The disparity highlights a troubling reality: individuals can access illicit drugs in Potter County, face arrest for their use, and receive treatment while incarcerated—but struggle to continue that treatment upon release.

Local efforts aimed at rehabilitation do exist. Potter County Human Services operates a reentry program that includes transitional housing, designed to support individuals returning to the community after incarceration. In the courtroom, Judge Stephen B. Minor has in recent years emphasized rehabilitation over punitive measures in many cases involving substance use.

Yet without consistent access to medications like Suboxone, those efforts may fall short.

Public health experts widely recognize medication-assisted treatment as one of the most effective tools for reducing opioid dependence and preventing overdose deaths. Barriers to access—particularly in rural areas—can increase the likelihood of relapse, overdose, and recidivism.

Advocates argue that the current landscape in Potter County creates a cycle that is difficult to break.

“It’s easier to get illegal drugs than it is to get the medication needed to stop using them,” one local observer noted. “That’s a system set up for failure.”

As the opioid crisis continues to impact rural communities across Pennsylvania, questions remain about how local policies, economic pressures, and regulatory frameworks intersect—and whether changes can be made to expand access to life-saving treatment.

For now, many Potter County residents seeking recovery are left navigating a system where help is available—but not always within reach.